Featured news in The Life Sciences Report



ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors (2/21/2019)

view
 


DURECT Corp. (DRRX:NASDAQ)
DURECT Corporation to Participate in the Berenberg NASH Day (2/21/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
Agios' Tibsovo Gets FDA Priority Review in First-Line Cancer (2/21/2019)

view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Mesoblast Reports Financial Results and Operational Highlights for the First Half Ended December 31, 2018 (2/20/2019)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm to Present at 2019 Sachs Associates European Life Sciences CEO Forum in Zurich, Switzerland (2/21/2019)

view
 


Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB)
Leadership Changes to Help Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) Become a Leading Cannabis Formulation Company (2/19/2019)

view
 


Global Compliance Applications Corp. (APP:CSE; FUAPF:OTCQB; 2FA:FSA)
Streetwise Reports Examines Company Bringing Advanced Technology to the Cannabis Space (2/20/2019)

view
 


Avivagen Inc. (VIV:TSX.V; VIVXF:OTCQB)
Avivagen enters into Partnership with CSA to Sell and Distribute OxC-beta(TM) Livestock in the United States (2/20/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
Ultragenyx (RARE) Posts Narrower-Than-Expected Loss in Q4 (2/20/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
How to Replicate Hedge Fund Strategies with ETFs (2/19/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Intercept Pharmaceuticals (ICPT) Surges: Stock Moves 6.1% Higher (2/20/2019)

view
 


Global Compliance Applications Corp. (APP:CSE; FUAPF:OTCQB; 2FA:FSA)
Los Angeles Based Downtown Meds to Use and Resell Citizen Green Technology (2/19/2019)

view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Final Patient Dosed in Mesoblast Phase 3 Trial of Revascor Cell Therapy for Advanced Heart Failure (2/19/2019)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Issues a Statement to Patients and Shareholders (2/19/2019)

view